Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-07 6:55 pm Sale | 2023-12-31 | 13G | Theratechnologies Inc. THTX | HIRSCHMAN ORIN | 3,719,302 8.100% | -429,761 (-10.36%) | Filing History |
| 2024-02-07 6:55 pm Sale | 2023-12-31 | 13G | TELA Bio, Inc. TELA | HIRSCHMAN ORIN | 1,377,945 5.600% | -301,336 (-17.94%) | Filing History |
| 2024-02-07 6:55 pm Purchase | 2023-12-31 | 13G | Vaccinex, Inc. VCNX | HIRSCHMAN ORIN | 89,076 9.900% | 977 (+1.11%) | Filing History |
| 2024-02-07 09:22 am Purchase | 2024-02-01 | 13G | Kiora Pharmaceuticals, Inc. KPRX | HIRSCHMAN ORIN | 255,556 9.900% | 255,556 (New Position) | Filing History |
| 2024-02-07 09:18 am Purchase | 2024-02-06 | 13G | Immix Biopharma, Inc. IMMX | HIRSCHMAN ORIN | 1,455,000 5.800% | 1,455,000 (New Position) | Filing History |
| 2024-02-07 09:15 am Purchase | 2024-01-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | HIRSCHMAN ORIN | 1,061,509 8.200% | 1,061,509 (New Position) | Filing History |
| 2024-01-25 07:03 am Sale | 2024-01-18 | 13G | Transphorm, Inc. TGAN | HIRSCHMAN ORIN | 1,263,282 2.000% | -3,831,690 (-75.21%) | Filing History |
| 2024-01-09 08:12 am Purchase | 2023-12-27 | 13G | Delcath Systems, Inc. DCTH | HIRSCHMAN ORIN | 1,539,638 6.800% | 1,539,638 (New Position) | Filing History |
| 2024-01-04 06:02 am Sale | 2023-12-31 | 13G | GSI Technology, Inc. GSIT | HIRSCHMAN ORIN | 835,560 3.300% | -1,164,440 (-58.22%) | Filing History |
| 2023-12-21 10:34 am Sale | 2023-12-20 | 13G | CAMP4 Therapeutics Corporation CAMP | HIRSCHMAN ORIN | 0 0.000% | -101,215 (Position Closed) | Filing History |
| 2023-12-15 06:26 am Purchase | 2023-12-11 | 13G | IN8bio, Inc. INAB | HIRSCHMAN ORIN | 4,098,361 9.400% | 4,098,361 (New Position) | Filing History |
| 2023-12-08 06:10 am Purchase | 2023-12-07 | 13G | Red Cat Holdings, Inc. RCAT | HIRSCHMAN ORIN | 5,276,104 7.400% | 5,276,104 (New Position) | Filing History |
| 2023-12-05 06:01 am Purchase | 2023-11-07 | 13G | Cellectar Biosciences, Inc. CLRB | HIRSCHMAN ORIN | 1,915,220 9.900% | 1,915,220 (New Position) | Filing History |
| 2023-12-04 4:05 pm Sale | 2023-12-01 | 13G | Airgain, Inc. AIRG | HIRSCHMAN ORIN | 0 0.000% | -725,484 (Position Closed) | Filing History |
| 2023-12-04 4:05 pm Purchase | 2023-09-18 | 13G | Elutia Inc. ELUT | HIRSCHMAN ORIN | 1,869,530 9.900% | 1,869,530 (New Position) | Filing History |
| 2023-11-29 4:32 pm Purchase | 2023-10-26 | 13G | Theratechnologies Inc. THTX | HIRSCHMAN ORIN | 4,149,063 9.000% | 4,149,063 (New Position) | Filing History |
| 2023-11-28 4:05 pm Sale | 2023-11-28 | 13G | Annovis Bio, Inc. ANVS | HIRSCHMAN ORIN | 470,000 4.580% | -103,941 (-18.11%) | Filing History |
| 2023-11-08 07:02 am Purchase | 2023-10-31 | 13G | Annovis Bio, Inc. ANVS | HIRSCHMAN ORIN | 573,941 5.600% | 245,583 (+74.79%) | Filing History |
| 2023-10-11 12:28 pm Purchase | 2023-09-28 | 13G | Vaccinex, Inc. VCNX | HIRSCHMAN ORIN | 88,099 9.900% | 88,099 (New Position) | Filing History |
| 2023-09-29 2:16 pm Purchase | 2023-09-28 | 13G | CAPSTONE GREEN ENERGY CORPORAT CGRNQ | HIRSCHMAN ORIN | 1,800,000 9.800% | 1,800,000 (New Position) | Filing History |